Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.

BMC Urol · 2020 · PMC7592533 · PMID 33115461

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results revealed a highly significant signature for both prototypical (Fig. 5 d) and atypical SCPC (Fig. 5 e) when compared to prototypical AdPC.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.